Hierarchical control of cardiomyocyte maturation and ischaemia sensitivity by metabolic culture conditions

This study demonstrates that the metabolic composition of culture media serves as a dominant regulator of human induced pluripotent stem cell-derived cardiomyocyte maturation and their susceptibility to ischaemia-reperfusion injury, thereby establishing a critical framework for improving the physiological fidelity of cardiac injury models.

The Gist

The Big Picture: Why This Matters

Imagine you are trying to build a realistic model of a human heart to test why heart attacks happen and how to stop them. Scientists use "mini-hearts" grown from stem cells (called hiPSC-CMs) to do this.

However, there's a problem: These mini-hearts are like toddlers. They are immature. Real adult hearts are like marathon runners that run on a very specific, high-efficiency fuel (fatty acids). The mini-heart "toddlers" run on a different, simpler fuel (sugar) and are much tougher when oxygen runs out.

Because they are so different from adult hearts, these mini-hearts often fail to predict what happens in a real human heart attack. This paper asks: "How do we stop treating these cells like toddlers and start treating them like marathon runners so they react to heart attacks the way real hearts do?"

---

The Experiment: The "Gym Training" Analogy

The researchers realized that the way scientists "raise" these cells in the lab changes how they behave. They tested four main variables, which we can think of as different parts of a training regimen:

1. The Re-Plating (Moving House): Taking the cells and moving them to a new dish.
2. The Backbone Medium (The Diet): The main liquid food the cells drink.
3. The Supplements (Vitamins & Protein Shakes): Extra things added to the diet to boost growth.
4. The Maturation Factors (The Coach's Drills): Specific signals telling the cells to grow up.

They wanted to see which combination made the cells act most like adult hearts and, crucially, which combination made them vulnerable to a simulated heart attack (Ischaemia-Reperfusion Injury).

Key Findings (The "Aha!" Moments)

1. Moving House Makes Them Grow Up

When the scientists moved the cells to a new dish (re-plating), especially if they spread them out a bit, the cells started acting more like adults.

• Analogy: Think of a child who is comfortable in a crib. When you move them to a big bed and give them some space, they start walking and running.
• Result: These "moved" cells got stronger and beat better, but they also became more fragile. When the researchers simulated a heart attack (cutting off oxygen), these "grown-up" cells died much faster than the "baby" cells. This is actually good news for research, because real adult hearts do die quickly during a heart attack. The model finally matched reality!

2. The Diet is the Boss (The Most Important Finding)

The researchers tested two main "diets" (backbone media):

• Diet A (RPMI+B27): High in sugar (glucose). This is like feeding a toddler candy and juice.
• Diet B (DMEM+FA): No sugar, but full of fatty acids. This is like feeding an adult a steak and healthy fats.

The Result:

• Cells on the Sugar Diet stayed immature. They were tough and survived the simulated heart attack easily (because they are used to sugar).
• Cells on the Fat Diet instantly transformed into "adult" cells. They started burning fat for energy, just like a real heart.
• The Catch: Because they were now burning fat, they became extremely sensitive to oxygen loss. When the oxygen was cut, they crashed and died, just like a real human heart during a heart attack.

3. The "Coach's Drills" Only Work If the Diet is Right

Scientists often add special "vitamins" or "hormones" (supplements) to try to force cells to mature.

• The Discovery: If you feed the cells the Sugar Diet, adding these special supplements helps them grow up a little bit.
• The Twist: If you feed them the Fat Diet, they are already fully grown. Adding the supplements does almost nothing extra.
• Analogy: Imagine you have a car. If you put premium gas in it (Fat Diet), the engine runs perfectly. Adding a turbocharger (supplements) doesn't help much because the car is already running at peak efficiency. But if you put cheap gas in it (Sugar Diet), the turbocharger might give it a little boost, but it still won't run like a race car.

The Conclusion: The "Hierarchical" Rule

The paper's main takeaway is that the diet (metabolic environment) is the boss.

It doesn't matter how many "vitamins" or "drills" you add if the base diet is wrong. The type of food the cells eat first determines their entire identity.

• Sugar-based food = Immature, tough, bad for modeling heart attacks.
• Fat-based food = Mature, fragile, perfect for modeling heart attacks.

Why This Changes Everything

For years, scientists tried to make these mini-hearts mature by adding complex chemicals. This paper says, "Stop overcomplicating it. Just change the food."

By switching the diet to one that mimics an adult heart's natural fuel source (fatty acids), researchers can now create mini-hearts that accurately predict how real human hearts will fail during a heart attack. This opens the door to testing new drugs that could actually save lives, rather than just working on "toddler" hearts that don't reflect the real problem.

Technical Summary

1. Problem Statement

Ischaemic heart disease (IHD) is the leading cause of global mortality, yet no therapies effectively prevent cardiomyocyte death during acute ischaemia–reperfusion injury (IRI). While human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer a platform for modeling cardiac injury, they suffer from a critical limitation: they retain a fetal-like phenotype.

• Metabolic Mismatch: Immature hiPSC-CMs rely primarily on glycolysis, whereas adult cardiomyocytes depend on mitochondrial oxidative phosphorylation (fatty acid $\beta$-oxidation).
• Consequence: Glycolysis-dominant cells are naturally more tolerant of hypoxia, causing immature hiPSC-CMs to underestimate injury severity in in vitro IRI models.
• Knowledge Gap: It is unclear how specific experimental variables used during the preparation of endpoint assays (replating, media, substrates) influence the maturation state and subsequent susceptibility to IRI.

2. Methodology

The study employed a multi-pronged approach combining bioinformatics, transcriptomics, and functional assays:

• Bioinformatics (CMPortal): The authors analyzed 322 hiPSC-CM differentiation protocols from the CMPortal database. They used decision tree-based feature importance analysis (Shannon entropy and Gini impurity) to correlate protocol variables (media, coatings, metabolites) with maturation outcomes and disease modeling applications.
• Cell Culture & Differentiation:
  • Used the WTC-11 hiPSC line differentiated via a monolayer small-molecule protocol.
  • Replating: Cells were replated at Day 15 to transition from differentiation to endpoint assays.
  • Backbone Media Comparison: Compared glucose-based RPMI+B27 vs. fatty acid-containing, glucose-free DMEM+FA.
  • Perturbation Screen: Tested various metabolic substrates (palmitic acid, galactose), signaling molecules (T3, Torin1, GW7647), and matrix coatings.
• Functional Assays:
  • Contractility: Measured using MUSCLEMOTION (image-based) and CardioExcyte 96 (impedance-based) for amplitude, beat rate, and upstroke velocity.
  • IRI Model: Cells were subjected to hypoxia (0.5% O$_2$, 18h) followed by normoxic reperfusion. Cell death was quantified via LDH release.
• Molecular Profiling:
  • CAGE-Seq & RNA-Seq: Used to identify differentially expressed genes (DEGs) and transcriptional programs.
  • scDRS & Heritability Analysis: Applied Single-cell Disease Relevance Score (scDRS) and SNP-based heritability analysis (SBayesRC) using UK Biobank GWAS data to link gene expression changes to human cardiac traits and disease risk loci.

3. Key Contributions & Findings

A. Replating Induces Maturation and Increases IRI Susceptibility

• Observation: Replating hiPSC-CMs (specifically at lower densities) triggers functional and molecular maturation.
• Evidence: Increased contraction amplitude, upregulation of mature myofilament genes (MYH7, TNNI3), and downregulation of glycolytic genes (HK2, GAPDH).
• Outcome: Replated cells showed significantly higher LDH release (cell death) after IRI compared to non-replated cells, indicating that maturation increases vulnerability to ischaemic stress.

B. Backbone Medium Dictates Metabolic State and Injury Response

• Comparison: DMEM+FA (fatty acid-rich, glucose-free) vs. RPMI+B27 (glucose-rich).
• Results:
  • DMEM+FA cells exhibited superior contractile maturation (higher amplitude, velocity) and upregulated fatty acid $\beta$-oxidation pathways.
  • DMEM+FA cells were significantly more susceptible to IRI-induced cell death than RPMI+B27 cells.
  • Genetic Link: Genes upregulated in DMEM+FA were enriched for loci associated with Ischaemic Heart Disease (IHD) and Acute Myocardial Infarction (AMI) in human GWAS data, whereas RPMI+B27 genes were linked to general cardiac structure/function.

C. Hierarchical Control: Metabolic Context Overrides Supplements

• Hypothesis: Do maturation supplements (e.g., T3, fatty acids) further improve cells already in a mature metabolic state?
• Finding:
  • In RPMI+B27 (immature baseline), adding metabolic supplements (palmitic acid, galactose) or signaling molecules (T3) significantly improved contractility and increased IRI susceptibility.
  • In DMEM+FA (mature baseline), adding the same supplements produced minimal additional improvement in contractility or IRI susceptibility.
• Conclusion: The metabolic composition of the backbone medium establishes a "baseline maturation state" that hierarchically dominates the effects of individual maturation cues. Once a cell is metabolically primed by fatty acids, additional cues offer diminishing returns.

4. Significance

• Physiological Fidelity: The study demonstrates that metabolic environment is the primary driver of injury susceptibility in hiPSC-CM models. Using fatty acid-based media creates a phenotype that more accurately mimics the energetic vulnerability of adult human myocardium during IRI.
• Experimental Design Framework: It challenges the notion of a single "optimal" maturation protocol. Instead, it proposes a hierarchical model where the backbone medium sets the ceiling for maturation and disease relevance.
• Translational Impact: By defining culture conditions that align metabolic maturation with physiologically relevant injury responses, this work provides a framework for:
  1. Improving the predictive power of in vitro cardiac toxicity and efficacy screens.
  2. Developing better models for testing cardioprotective therapies against ischaemia-reperfusion injury.
  3. Standardizing protocols to ensure that disease modeling reflects the true pathophysiology of adult cardiac disease.

In summary, the paper establishes that metabolic context is the dominant regulator of hiPSC-CM maturation and ischaemia sensitivity, with fatty acid-based media being essential for modeling adult-like cardiac injury responses.